Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	16,693	11,385	11,994	15,527	11,138	5,917
Market Cap Growth	50.84%	-5.08%	-22.75%	39.41%	88.22%	14.66%
Enterprise Value	18,500	13,122	13,710	17,024	12,784	7,126
Last Close Price	18.90	12.89	13.58	17.58	12.61	6.65
PE Ratio	-	-	-	-	361.52	-
Forward PE	-	9.21	9.21	9.21	9.21	9.21
PS Ratio	18.59	19.29	27.80	22.05	15.13	8.20
PB Ratio	25.06	19.07	15.31	11.97	6.76	3.53
P/TBV Ratio	44.43	39.92	22.37	15.44	8.43	4.48
P/FCF Ratio	129.52	232.96	-	-	-	-
P/OCF Ratio	48.06	69.12	-	982.28	71.02	123.30
PEG Ratio	-	0.73	0.73	0.73	0.73	0.73
EV/Sales Ratio	20.60	22.23	31.78	24.17	17.37	9.87
EV/EBITDA Ratio	72.09	115.59	-	-	-	-
EV/EBIT Ratio	165.18	-	-	-	-	-
EV/FCF Ratio	143.53	268.51	-	-	-	-
Debt / Equity Ratio	2.90	3.01	2.59	1.39	1.09	1.16
Debt / EBITDA Ratio	7.52	15.72	-	-	-	-
Debt / FCF Ratio	14.97	36.79	-	-	-	-
Asset Turnover	0.29	0.19	0.13	0.19	0.19	0.17
Inventory Turnover	1.50	1.44	1.52	1.12	1.58	0.91
Quick Ratio	0.16	0.14	0.36	0.52	1.28	0.74
Current Ratio	0.37	0.33	0.48	0.71	1.55	0.95
Return on Equity (ROE)	-10.67%	-26.10%	-49.56%	-25.30%	1.71%	-31.16%
Return on Assets (ROA)	2.23%	-0.64%	-6.74%	-3.03%	-4.26%	-7.79%
Return on Capital (ROIC)	2.70%	-0.78%	-7.85%	-3.48%	-4.78%	-8.64%
Return on Capital Employed (ROCE)	6.80%	-2.00%	-20.00%	-7.40%	-8.50%	-18.70%
Earnings Yield	-0.40%	-1.52%	-4.28%	-2.39%	0.28%	-10.30%
FCF Yield	0.77%	0.43%	-0.71%	-1.12%	-0.38%	-3.31%
Payout Ratio	-	-	-	-	375.37%	-
Buyback Yield / Dilution	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%
Total Shareholder Return	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.